Bank of Montreal
DNTH icon

Bank of Montreal’s Dianthus Therapeutics DNTH Stock Holding History

Bank of Montreal’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-38
Closed -$8K – 3986
2021
Q1 		$8K Sell
38
-163
-81% -$27.4K ﹤0.01% 4445
2020
Q4 		$28K Buy
201
+141
+235% +$16K ﹤0.01% 4254
2020
Q3 		$7K Sell
60
-30
-33% -$3.56K ﹤0.01% 4270
2020
Q2 		$13K Buy
90
+77
+592% +$10.8K ﹤0.01% 4033
2020
Q1 		$1K Sell
13
-153
-92% -$28.4K ﹤0.01% 3948
2019
Q4 		$40K Buy
166
+61
+58% +$11.4K ﹤0.01% 3952
2019
Q3 		$17K Buy
105
+3
+3% +$570 ﹤0.01% 4168
2019
Q2 		$24K Buy
+102
New +$25.2K ﹤0.01% 4068
2019
Q1 		– Sell
-3
Closed – – 4411
2018
Q4 		$0 Buy
3
+1
+50% +$136 ﹤0.01% 4699
2018
Q3 		$0 Buy
+2
New +$421 ﹤0.01% 4755

Other funds holding DNTH

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of Montreal's DNTH Position: Q2 2021 in Review

Bank of Montreal sold out of Dianthus Therapeutics (DNTH) in Q2 2021, closing a stake of 38 shares — an estimated $8K sold.

Bank of Montreal first reported a position in DNTH in Q3 2018 and held it in 10 quarters. The position peaked at $40K in Q4 2019. 97 funds tracked by Wall St. Rank hold DNTH as of Q2 2021.

  • Bank of Montreal reported no remaining Dianthus Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 38 Dianthus Therapeutics shares in Q2 2021, an estimated $8K.
  • Bank of Montreal first reported a position in Dianthus Therapeutics in Q3 2018 and held it in 10 quarters.
  • Bank of Montreal's Dianthus Therapeutics position peaked at $40K in Q4 2019.
  • 97 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.